NASDAQ:AIMD Ainos Q2 2026 Earnings Report $1.23 -0.06 (-4.65%) Closing price 03:58 PM EasternExtended Trading$1.24 +0.01 (+0.81%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Ainos EPS ResultsActual EPS-$0.62Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAinos Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAinos Announcement DetailsQuarterQ2 2026Date8/3/2026TimeAfter Market ClosesConference Call DateMonday, August 3, 2026Conference Call Time7:00AM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Ainos Earnings HeadlinesFinancial Analysis: Ainos (NASDAQ:AIMD) versus Everpure (NYSE:P)October 6 at 2:15 AM | americanbankingnews.comAinos, Inc.: Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year ContractSeptember 29, 2026 | finanznachrichten.deTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.October 7 at 1:00 AM | Banyan Hill Publishing (Ad)Ainos, Inc. (NASDAQ:AIMD) Shares Shorted: Short Interest Up 172.6% in SeptemberSeptember 27, 2026 | americanbankingnews.comAinos shares rise 6.9% after receiving initial AI nose semiconductor ordersSeptember 14, 2026 | msn.comAinos, Inc.: Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI EraSeptember 9, 2026 | finanznachrichten.deSee More Ainos Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Ainos? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ainos and other key companies, straight to your email. Email Address About AinosAinos (NASDAQ:AIMD) (NASDAQ: AIMD) is a healthcare technology company developing solutions in artificial intelligence, point-of-care testing and telehealth. The company focuses on technologies intended to support non-invasive disease screening, decentralized healthcare delivery and improved access to diagnostic services. Ainos’ AI Nose platform uses artificial intelligence and analysis of volatile organic compounds to identify patterns that may be associated with certain health conditions. The company is also developing point-of-care testing products and related diagnostic applications designed for use outside traditional laboratory settings. In addition, Ainos has worked on telehealth solutions and therapeutic products, including its VELDONA low-dose interferon-alpha platform. The company’s activities and product development efforts are focused primarily on healthcare applications in the United States and Asia-Pacific markets.View Ainos ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Penguin Solutions Is Soaring as AI Memory Demand ExplodesWall Street Is Betting These 3 Beaten-Down Stocks Have More Room to RunLamb Weston’s Turnaround Is Starting to Look RealRPM International’s Dividend King Status Just Got StrongerAI Chip Demand Gives Linde a New Growth CatalystAllient’s Data Center and Defense Momentum Is Raising the StakesInvenTrust’s Sell-Off Opens a Potential Entry Point Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
